iXgene Inc. (Headquarters: Shinjuku-ku, Tokyo; CEO: Toshiharu Furukawa) has formalized a collaborative research agreement with C4U Inc. (Headquarters: Suita, Osaka; President and CEO: Akimitsu Hirai). This partnership focuses on advancing research related to C4U’s proprietary CRISPR-Cas3 genome editing technology.
Click the link below to read the full press release.